Results from CARTITUDE-1: A Phase 1b/2 Study of JNJ-4528, a CAR-T Cell Therapy Directed Against B-Cell Maturation Antigen (BCMA), in Patients with Relapsed and/or Refractory Multiple Myeloma (R/R MM)Deepu Madduri, Jesús G. Berdeja, Enrique Zudaire et al.|Blood|2019Cited by 120